FI80598B - Foerfarande foer framstaellning av en enzymberedning. - Google Patents
Foerfarande foer framstaellning av en enzymberedning. Download PDFInfo
- Publication number
- FI80598B FI80598B FI842555A FI842555A FI80598B FI 80598 B FI80598 B FI 80598B FI 842555 A FI842555 A FI 842555A FI 842555 A FI842555 A FI 842555A FI 80598 B FI80598 B FI 80598B
- Authority
- FI
- Finland
- Prior art keywords
- enzyme
- enzymes
- process according
- preparation
- krill
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 claims description 119
- 108090000790 Enzymes Proteins 0.000 claims description 119
- 239000000203 mixture Substances 0.000 claims description 44
- 238000002360 preparation method Methods 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 18
- 241001465754 Metazoa Species 0.000 claims description 13
- 150000002632 lipids Chemical class 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 239000007857 degradation product Substances 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000018389 Exopeptidases Human genes 0.000 claims description 2
- 108010091443 Exopeptidases Proteins 0.000 claims description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 150000003904 phospholipids Chemical class 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 238000000638 solvent extraction Methods 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 111
- 230000000694 effects Effects 0.000 description 30
- 241000239366 Euphausiacea Species 0.000 description 26
- 210000001519 tissue Anatomy 0.000 description 22
- 239000004365 Protease Substances 0.000 description 17
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 239000003599 detergent Substances 0.000 description 12
- 230000004580 weight loss Effects 0.000 description 12
- 238000000746 purification Methods 0.000 description 11
- 102000009123 Fibrin Human genes 0.000 description 10
- 108010073385 Fibrin Proteins 0.000 description 10
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 229950003499 fibrin Drugs 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 102000004142 Trypsin Human genes 0.000 description 9
- 108090000631 Trypsin Proteins 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 210000002268 wool Anatomy 0.000 description 9
- 206010052428 Wound Diseases 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 239000004744 fabric Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 108090000270 Ficain Proteins 0.000 description 7
- 108090000526 Papain Proteins 0.000 description 7
- 108010056079 Subtilisins Proteins 0.000 description 7
- 102000005158 Subtilisins Human genes 0.000 description 7
- 230000015556 catabolic process Effects 0.000 description 7
- 239000000356 contaminant Substances 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 229940055729 papain Drugs 0.000 description 7
- 235000019834 papain Nutrition 0.000 description 7
- 102000035195 Peptidases Human genes 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000019836 ficin Nutrition 0.000 description 6
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000002797 proteolythic effect Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 108010086613 Streptodornase and Streptokinase Proteins 0.000 description 5
- -1 bandage Substances 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 229940079919 digestives enzyme preparation Drugs 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 230000004584 weight gain Effects 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- 241001417902 Mallotus villosus Species 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 244000038022 Chenopodium capitatum Species 0.000 description 3
- 235000004391 Chenopodium capitatum Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000001338 necrotic effect Effects 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 235000019890 Amylum Nutrition 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000239370 Euphausia superba Species 0.000 description 2
- 108010088842 Fibrinolysin Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 108010023197 Streptokinase Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000008365 aqueous carrier Substances 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- 239000001639 calcium acetate Substances 0.000 description 2
- 235000011092 calcium acetate Nutrition 0.000 description 2
- 229960005147 calcium acetate Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- 229940001501 fibrinolysin Drugs 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 229960003511 macrogol Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 229960004533 streptodornase Drugs 0.000 description 2
- 229960005202 streptokinase Drugs 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- MGGVALXERJRIRO-UHFFFAOYSA-N 4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-2-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-1H-pyrazol-5-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)O MGGVALXERJRIRO-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108010071195 Nucleotidases Proteins 0.000 description 1
- 102000007533 Nucleotidases Human genes 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000000678 effect on lipid Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 108010016297 plasmin drug combination deoxyribonuclease Proteins 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Enzymes And Modification Thereof (AREA)
Claims (7)
1. Förfarande för framställning av en enzym-beredning, som har förmäga att avlägsna biologiska 5 föroreningar, särskilt föroreningar innehällande bäde peptider och lipider, kännetecknat av att man homogeniserar djur av ordningen Euphausiaceae och genom extraktion med ett lösningsmedel isolerar en enzymberedning innehällande en blandning av enzymer, 10 väri ingär säväl endo- som exopeptidaser.
2. Förfarande enligt patentkravet 1, kännetecknat av att frän homogenisatet eventuellt avlägsnar eventuella lipider.
3. Förfarande enligt patentkravet 1 eller 2, 15 kännetecknat av att enzymberedningen steri- liseras.
4. Förfarande enligt nägot av patentkraven 1- ^ 3, kännetecknat av att extraktionen utförs med vatten eller ett vattenhaltigt lösningsmedel. 20
5. Förfarande enligt nägot av patentkraven 1- 4, kännetecknat av att man avlägsnar lipider frän enzymberedningen och lyofiliserar denna.
6. Förfarande enligt nägot av patentkraven 1- 5, kännetecknat av att man isolerar en-25 zymer, som har en molekylvikt frän ca 15.000 tili ca 80.000 Dalton eller är aktiva aggregat av sädana enzymer.
7. Förfarande enligt nägot av patenkraven 1- 6, kännetecknat av att i den isolerade 30 enzymblandningen ingär enzymer, som är kapabla att upplösa och avlägsna föroreningar innehällande blandnin-gar av ämnen valda bland lipider, fosfolipider, prote-iner, peptider, nukleinsyror, polysackarider, mucopoly-sackarider och nedbrytningsprodukter av dessa ämnen.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8206022 | 1982-10-25 | ||
| SE8206022A SE8206022D0 (sv) | 1982-10-25 | 1982-10-25 | Nedbrytning av nekrotisk vevnad, fibrin, pus, purulent exudat, blodkoagler medelst enzymer fran fisk (lodde), skaldjur (krill), vexter (papain,ficin) samt alcalase och pancreatin |
| SE8302268 | 1983-04-22 | ||
| SE8302268A SE8302268L (sv) | 1983-04-22 | 1983-04-22 | Ny kombination av proteolytiska och lipolytiska enzymer lemplig som tvettkomposition |
| PCT/SE1983/000359 WO1984001715A1 (en) | 1982-10-25 | 1983-10-24 | Enzyme composition for therapeutical and/or non-therapeutical cleaning, the use thereof and preparation of the composition |
| SE8300359 | 1983-10-24 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI842555A FI842555A (fi) | 1984-06-25 |
| FI842555A0 FI842555A0 (fi) | 1984-06-25 |
| FI80598B true FI80598B (fi) | 1990-03-30 |
| FI80598C FI80598C (sv) | 1990-07-10 |
Family
ID=26658270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI842555A FI80598C (sv) | 1982-10-25 | 1984-06-25 | Förfarande för framställning av en enzymberedning |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4963491A (sv) |
| EP (1) | EP0107634B1 (sv) |
| JP (2) | JPS59501908A (sv) |
| AU (1) | AU573730B2 (sv) |
| CA (1) | CA1220740A (sv) |
| DE (1) | DE3379589D1 (sv) |
| DK (1) | DK166566B1 (sv) |
| FI (1) | FI80598C (sv) |
| WO (1) | WO1984001715A1 (sv) |
Families Citing this family (102)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE454566B (sv) * | 1984-04-24 | 1988-05-16 | Lars G I Hellgren | Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus |
| JPS6130527A (ja) * | 1984-07-20 | 1986-02-12 | Kao Corp | 血栓溶解剤 |
| SE8703064D0 (sv) * | 1987-08-06 | 1987-08-06 | Viggo Mohr | Method for isolating active enzyme preparations from animal tissues |
| SE8801701D0 (sv) * | 1988-05-05 | 1988-05-05 | Pharmacia Ab | Production technology based on enzymic method |
| NO164844C (no) * | 1988-10-24 | 1990-11-21 | Norsk Hydro As | Fremgangsmaate ved utvinning av enzymer fra krepsdyr. |
| US5258304A (en) * | 1989-10-27 | 1993-11-02 | Genencor International, Inc. | Method of removing microorganisms from surfaces with Type II endoglycosidase |
| US5238843A (en) * | 1989-10-27 | 1993-08-24 | Genencor International, Inc. | Method for cleaning a surface on which is bound a glycoside-containing substance |
| GB2248858B (en) * | 1990-10-17 | 1994-04-27 | Metra Oy Ab | Vacuum toilet system with treated rinse liquid |
| CA2112123A1 (en) * | 1991-06-24 | 1993-01-07 | Bill H. Mcanalley | Wound cleanser |
| US5958406A (en) * | 1994-11-22 | 1999-09-28 | Phairson Medical Inc. | Acne treatment with multifunctional enzyme |
| US6030612A (en) * | 1994-11-22 | 2000-02-29 | Phairson Medical Inc. | Antimicrobial uses of multifunctional enzyme |
| US7947270B2 (en) * | 1992-05-22 | 2011-05-24 | Arcimboldo Ab | Removing dental plaque with krill enzymes |
| US5945102A (en) * | 1994-11-22 | 1999-08-31 | Phairson Medical Inc. | Crustacean and fish derived multifunctional enzyme |
| SE9201628D0 (sv) * | 1992-05-22 | 1992-05-22 | Phairson Medical Ab | Pharmaceutical composition |
| US20060134641A1 (en) * | 1992-05-22 | 2006-06-22 | Franklin Richard L | Treating viral infections with krill enzymes |
| JPH0776700A (ja) * | 1993-07-14 | 1995-03-20 | Senju Pharmaceut Co Ltd | コンタクトレンズ用剤の安定化方法 |
| SE9303899D0 (sv) * | 1993-11-22 | 1993-11-22 | Phairson Medical Inc | Läkemedel |
| EP0759764A1 (en) * | 1994-06-07 | 1997-03-05 | Kristian Hellgren | Composition for dental use comprising krill enzyme |
| US6232088B1 (en) | 1995-02-08 | 2001-05-15 | Phairson Medical, Inc. | Treatment and prevention of immune rejection reactions |
| US6040155A (en) * | 1996-08-28 | 2000-03-21 | Kay; John | Multifunctional protein and DNA sequence encoding same |
| US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
| US7192450B2 (en) | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
| US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
| US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| CA2251265A1 (en) | 1998-10-21 | 2000-04-21 | Universite De Sherbrooke | Process for lipid extraction of aquatic animal tissues producing a dehydrated residue |
| WO2002000908A2 (en) * | 2000-09-25 | 2002-01-03 | Novozymes A/S | Methods for processing crustacean material |
| US6548556B2 (en) | 2000-12-27 | 2003-04-15 | Healthpoint, Ltd. | Stable enzymatic wound debrider |
| US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US20030032874A1 (en) | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
| US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
| US8030348B2 (en) | 2001-07-27 | 2011-10-04 | Neptune Technologies & Bioressources, Inc. | Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications |
| US7497827B2 (en) | 2004-07-13 | 2009-03-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
| US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
| US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
| US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| US7223386B2 (en) * | 2002-03-11 | 2007-05-29 | Dow Corning Corporation | Preparations for topical skin use and treatment |
| US7226978B2 (en) | 2002-05-22 | 2007-06-05 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
| WO2004056985A2 (ja) * | 2002-12-19 | 2004-07-08 | Nippon Suisan Kaisha, Ltd. | オキアミ粗酵素液の製法、その粗酵素液とその凍結品、およびそれらを用いた飼料 |
| US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
| US7875293B2 (en) | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
| US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
| US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US7651596B2 (en) | 2005-04-08 | 2010-01-26 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
| US8285354B2 (en) | 2003-08-01 | 2012-10-09 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US8761856B2 (en) | 2003-08-01 | 2014-06-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US7519408B2 (en) | 2003-11-19 | 2009-04-14 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
| US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
| US7778680B2 (en) | 2003-08-01 | 2010-08-17 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US20100168543A1 (en) | 2003-08-01 | 2010-07-01 | Dexcom, Inc. | System and methods for processing analyte sensor data |
| US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
| US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
| US8233959B2 (en) | 2003-08-22 | 2012-07-31 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
| US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
| US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
| US8615282B2 (en) | 2004-07-13 | 2013-12-24 | Dexcom, Inc. | Analyte sensor |
| US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
| US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
| US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| EP2256493B1 (en) | 2003-12-05 | 2014-02-26 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
| US8774886B2 (en) | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
| US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| EP1711791B1 (en) | 2003-12-09 | 2014-10-15 | DexCom, Inc. | Signal processing for continuous analyte sensor |
| WO2009048462A1 (en) | 2007-10-09 | 2009-04-16 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
| US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
| US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
| US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
| US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US7202074B2 (en) * | 2004-07-22 | 2007-04-10 | University Of Chile | Protein and nucleic acid sequence encoding a KRILL-derived cold adapted trypsin-like activity enzyme |
| US20060182705A1 (en) * | 2005-02-11 | 2006-08-17 | Cruse Maria K | Composition for reduction and prevention of wrinkles on the skin |
| US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
| US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
| WO2007143225A2 (en) | 2006-06-07 | 2007-12-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
| PL2144625T3 (pl) * | 2006-12-05 | 2022-05-23 | Marizyme, Inc. | Kompozycja enzymatyczna o kontrolowanym uwalnianiu i sposoby zastosowania |
| US20200037874A1 (en) | 2007-05-18 | 2020-02-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
| US20080306434A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
| US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
| WO2009060013A2 (en) * | 2007-11-06 | 2009-05-14 | Kristian Hellgren | A method for treating ailments of the oral cavity with a krill enzyme composition |
| US9839395B2 (en) | 2007-12-17 | 2017-12-12 | Dexcom, Inc. | Systems and methods for processing sensor data |
| EP2252196A4 (en) | 2008-02-21 | 2013-05-15 | Dexcom Inc | SYSTEMS AND METHOD FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA |
| EP4374790A3 (en) | 2009-04-30 | 2024-07-31 | DexCom, Inc. | Performance reports associated with continuous sensor data from multiple analysis time periods |
| WO2011041463A2 (en) | 2009-09-30 | 2011-04-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
| NZ600167A (en) | 2009-10-29 | 2014-06-27 | Acasti Pharma Inc | Concentrated therapeutic phospholipid compositions |
| JP5637431B2 (ja) * | 2010-08-10 | 2014-12-10 | 独立行政法人国立高等専門学校機構 | オキアミ由来のタンパク質分解酵素の生成方法および当該酵素を用いたタンパク質分解方法 |
| JP6141827B2 (ja) | 2011-04-15 | 2017-06-07 | デックスコム・インコーポレーテッド | 検体を測定するシステムの作動方法及び該方法を実施するべく構成されたセンサシステム |
| KR20150002765A (ko) | 2012-04-05 | 2015-01-07 | 아르침볼도 아베 | 생물막의 제거에 사용하기 위한 남극 크릴새우 유래의 효소 혼합물 |
| EP3121272A1 (en) | 2015-07-24 | 2017-01-25 | Zymetech ehf. | Novel fish trypsin isoforms and their use |
| US20190120785A1 (en) | 2017-10-24 | 2019-04-25 | Dexcom, Inc. | Pre-connected analyte sensors |
| US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
| CN111432654A (zh) | 2017-12-04 | 2020-07-17 | 雾凇科技有限公司 | 从甲壳类捕获物中生产蛋白质磷脂复合物的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB284668A (en) * | 1927-02-03 | 1928-11-01 | Alfred Ehrenreich | Method of treatment of the glands of the plagiostomi with a view to obtaining a new description of chemical products |
| GB368888A (en) * | 1930-01-21 | 1932-03-17 | H Th Boehme Ag | Improvements in carrying out fermentation processes |
| GB377128A (en) * | 1931-03-11 | 1932-07-21 | H Th Boehme Ag | A process for the production of ferment preparations |
| US2503313A (en) * | 1947-04-14 | 1950-04-11 | Levin Ezra | Production of dried, defatted enzymatic material |
| FR1015566A (fr) * | 1948-04-15 | 1952-10-15 | Heviferm Lab G M B H | Procédé d'obtention de préparations stables de ferments, sous une quantité dosable, à partir d'intestins de poissons de mer ou d'eau douce et d'autres animaux aquatiques |
| US3003917A (en) * | 1959-01-14 | 1961-10-10 | Nat Drug Co | Wound healing composition |
| US3409719A (en) * | 1967-05-23 | 1968-11-05 | Baxter Laboratories Inc | Debridement agent |
| GB1273545A (en) * | 1968-06-24 | 1972-05-10 | Albright & Wilson | Multi-enzyme cleaning compositions |
| US3697451A (en) * | 1969-01-02 | 1972-10-10 | Witco Chemical Corp | Stable enzyme containing liquid detergent |
| US4307081A (en) * | 1974-01-08 | 1981-12-22 | Gerold K. V. Klein | Enzyme mixture |
-
1983
- 1983-10-24 WO PCT/SE1983/000359 patent/WO1984001715A1/en active IP Right Grant
- 1983-10-24 AU AU22041/83A patent/AU573730B2/en not_active Expired
- 1983-10-24 EP EP83850279A patent/EP0107634B1/en not_active Expired
- 1983-10-24 DE DE8383850279T patent/DE3379589D1/de not_active Expired
- 1983-10-24 JP JP58503493A patent/JPS59501908A/ja active Granted
- 1983-10-25 CA CA000439619A patent/CA1220740A/en not_active Expired
-
1984
- 1984-06-22 DK DK308684A patent/DK166566B1/da not_active IP Right Cessation
- 1984-06-25 FI FI842555A patent/FI80598C/sv not_active IP Right Cessation
-
1989
- 1989-01-27 US US07/302,190 patent/US4963491A/en not_active Expired - Lifetime
-
1992
- 1992-09-03 JP JP4236141A patent/JPH0662994B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US4963491A (en) | 1990-10-16 |
| JPH05262665A (ja) | 1993-10-12 |
| FI842555A (fi) | 1984-06-25 |
| WO1984001715A1 (en) | 1984-05-10 |
| FI80598C (sv) | 1990-07-10 |
| AU2204183A (en) | 1984-05-22 |
| AU573730B2 (en) | 1988-06-23 |
| JPS59501908A (ja) | 1984-11-15 |
| EP0107634A2 (en) | 1984-05-02 |
| CA1220740A (en) | 1987-04-21 |
| JPH0517209B2 (sv) | 1993-03-08 |
| FI842555A0 (fi) | 1984-06-25 |
| DK308684D0 (da) | 1984-06-22 |
| DK308684A (da) | 1984-06-22 |
| JPH0662994B2 (ja) | 1994-08-17 |
| EP0107634B1 (en) | 1989-04-12 |
| EP0107634A3 (en) | 1986-10-08 |
| DK166566B1 (da) | 1993-06-14 |
| DE3379589D1 (en) | 1989-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI80598B (fi) | Foerfarande foer framstaellning av en enzymberedning. | |
| US4801451A (en) | Cleaning with enzymes from krill | |
| Jimenez-Porras | Biochemistry of snake venoms | |
| JP5053096B2 (ja) | ブロメラインからの創傷清拭組成物及びその製造方法 | |
| DE69229134T2 (de) | Alkalische Proteinase und deren Verfahren zur Herstellung | |
| EP0838213B1 (en) | Use of Krill Enzymes for the Treatment of Dental Plaque | |
| Anheller et al. | Biochemical and biological profile of a new enzyme preparation from Antarctic krill (E. superba) suitable for debridement of ulcerative lesions | |
| DE69432795T2 (de) | Porphyromonas gingivalis arginin-spezifische proteinase kodierende sequenzen | |
| Yang et al. | Purification and characterization of chymotrypsins from the hepatopancreas of crucian carp (Carassius auratus) | |
| US5387517A (en) | Thiol activated protease from stem bromelain for treating devitalized tissue | |
| WO1998055604A1 (en) | Hydrophilic composition containing protease produced by vibrio | |
| US4873222A (en) | Placenta-derived anticoagulating substance | |
| KR100513301B1 (ko) | 발 세정용 조성물 | |
| KR100329962B1 (ko) | 피부표면의 케라틴층을 분해하는 단백질 분해효소와 이를 생산하는 미생물 및 그 배양액을 함유하는 화장품 조성물 | |
| KR20220123526A (ko) | 조성물 및 제조 방법 | |
| NO165093B (no) | Enzymsammensetning for rensing, bruken av den og framstilling av sammensetningen. | |
| CN1041170C (zh) | 菠萝蛋白酶脱痂制剂及其制备方法 | |
| KR100320948B1 (ko) | 상표초로부터분리·정제한혈전용해성세린프로테아제및그의제조방법 | |
| KR100426948B1 (ko) | 단백질 분해효소를 이용한 견의 정련방법 | |
| KR20090026446A (ko) | 마늘기름 추출방법 및 마늘기름을 함유하는 여드름 진정 및개선용 화장료 조성물 | |
| KR100453574B1 (ko) | 곤충 유래의 혈전용해성 세린프로테아제와 그 추출방법 및이를 이용한 식·의약조성물 | |
| FI109766B (sv) | Förfarande för framställning av proteolytisk blandning innehållande escharas | |
| KR100190331B1 (ko) | 콘텍트 렌즈용 동결 건조약제의 제조방법 | |
| JPH09224696A (ja) | アルカリプロテアーゼを用いた毛髪構成成分の採取法 | |
| Topalov et al. | Treatment of Purulent, Necrotic and Atonic Wounds with Necrolytin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: MEDISAN PHARMACEUTICALS AB |
|
| MA | Patent expired |
Owner name: ANTARCTIC PHARMA AB |